Global Anti-helminthic Drugs Market Research Report 2025(Status and Outlook)
Report Overview
Antihelmintics are a class of drugs used to treat parasitic infections caused by worms, including nematodes, tapeworms, flukes, etc. These drugs work by various mechanisms to kill or expel the parasites, helping to clear worm infections from the body. Helminths are parasites that can live in humans or animals and can cause a variety of diseases that affect the digestive system, respiratory system, blood system, etc.
This report provides a deep insight into the global Anti-helminthic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-helminthic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-helminthic Drugs market in any manner.
Global Anti-helminthic Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Fredun Pharmaceuticals Ltd
Salius Pharma
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Merck
Shanghai Tengrui Pharmaceutical Co.
Ltd.
Shaanxi Hanwang Pharmaceutical Co.
Ltd.
Beijing Taiyang Pharmaceutical Co.
Ltd.
Guilin Nanyao Pharmaceutical Co.
Ltd.
Fujian Dongrui Pharmaceutical Co.
Ltd.
Jiaozuo Furuitang Pharmaceutical Co.
Ltd.
Shaoxing Minsheng Pharmaceutical Co.
Ltd.
Chengdu Hengda Pharmaceutical Co.
Ltd.
China Resources Sanjiu (Beijing) Pharmaceutical Co.
Ltd.
Market Segmentation (by Type)
Praziquantel
Albendazole
Mimbendazole
Piperazine
Pyrantel Pamoate
Market Segmentation (by Application)
For Veterinary Use
For Human Use
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti-helminthic Drugs Market
Overview of the regional outlook of the Anti-helminthic Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-helminthic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-helminthic Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Antihelmintics are a class of drugs used to treat parasitic infections caused by worms, including nematodes, tapeworms, flukes, etc. These drugs work by various mechanisms to kill or expel the parasites, helping to clear worm infections from the body. Helminths are parasites that can live in humans or animals and can cause a variety of diseases that affect the digestive system, respiratory system, blood system, etc.
This report provides a deep insight into the global Anti-helminthic Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Anti-helminthic Drugs Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Anti-helminthic Drugs market in any manner.
Global Anti-helminthic Drugs Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
GlaxoSmithKline
Sequent Scientific
K.A. Malle Pharmaceuticals
Lasa Supergenerics Limited
Fredun Pharmaceuticals Ltd
Salius Pharma
Johnson & Johnson
Amneal Pharmaceuticals
Cadila Pharmaceuticals
Eipico
Esteve Pharmaceuticals
Merck
Shanghai Tengrui Pharmaceutical Co.
Ltd.
Shaanxi Hanwang Pharmaceutical Co.
Ltd.
Beijing Taiyang Pharmaceutical Co.
Ltd.
Guilin Nanyao Pharmaceutical Co.
Ltd.
Fujian Dongrui Pharmaceutical Co.
Ltd.
Jiaozuo Furuitang Pharmaceutical Co.
Ltd.
Shaoxing Minsheng Pharmaceutical Co.
Ltd.
Chengdu Hengda Pharmaceutical Co.
Ltd.
China Resources Sanjiu (Beijing) Pharmaceutical Co.
Ltd.
Market Segmentation (by Type)
Praziquantel
Albendazole
Mimbendazole
Piperazine
Pyrantel Pamoate
Market Segmentation (by Application)
For Veterinary Use
For Human Use
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Anti-helminthic Drugs Market
Overview of the regional outlook of the Anti-helminthic Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Anti-helminthic Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Anti-helminthic Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Anti-helminthic Drugs
1.2 Key Market Segments
1.2.1 Anti-helminthic Drugs Segment by Type
1.2.2 Anti-helminthic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-HELMINTHIC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-HELMINTHIC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Anti-helminthic Drugs Product Life Cycle
3.3 Global Anti-helminthic Drugs Revenue Market Share by Company (2020-2025)
3.4 Anti-helminthic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Anti-helminthic Drugs Company Headquarters, Area Served, Product Type
3.6 Anti-helminthic Drugs Market Competitive Situation and Trends
3.6.1 Anti-helminthic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-helminthic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-HELMINTHIC DRUGS VALUE CHAIN ANALYSIS
4.1 Anti-helminthic Drugs Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-HELMINTHIC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Anti-helminthic Drugs Market Porter's Five Forces Analysis
6 ANTI-HELMINTHIC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-helminthic Drugs Market Size Market Share by Type (2020-2025)
6.3 Global Anti-helminthic Drugs Market Size Growth Rate by Type (2021-2025)
7 ANTI-HELMINTHIC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-helminthic Drugs Market Size (M USD) by Application (2020-2025)
7.3 Global Anti-helminthic Drugs Sales Growth Rate by Application (2020-2025)
8 ANTI-HELMINTHIC DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Anti-helminthic Drugs Market Size by Region
8.1.1 Global Anti-helminthic Drugs Market Size by Region
8.1.2 Global Anti-helminthic Drugs Market Size Market Share by Region
8.2 North America
8.2.1 North America Anti-helminthic Drugs Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-helminthic Drugs Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-helminthic Drugs Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-helminthic Drugs Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-helminthic Drugs Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Basic Information
9.1.2 GlaxoSmithKline Anti-helminthic Drugs Product Overview
9.1.3 GlaxoSmithKline Anti-helminthic Drugs Product Market Performance
9.1.4 GlaxoSmithKline SWOT Analysis
9.1.5 GlaxoSmithKline Business Overview
9.1.6 GlaxoSmithKline Recent Developments
9.2 Sequent Scientific
9.2.1 Sequent Scientific Basic Information
9.2.2 Sequent Scientific Anti-helminthic Drugs Product Overview
9.2.3 Sequent Scientific Anti-helminthic Drugs Product Market Performance
9.2.4 Sequent Scientific SWOT Analysis
9.2.5 Sequent Scientific Business Overview
9.2.6 Sequent Scientific Recent Developments
9.3 K.A. Malle Pharmaceuticals
9.3.1 K.A. Malle Pharmaceuticals Basic Information
9.3.2 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Overview
9.3.3 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.3.4 K.A. Malle Pharmaceuticals SWOT Analysis
9.3.5 K.A. Malle Pharmaceuticals Business Overview
9.3.6 K.A. Malle Pharmaceuticals Recent Developments
9.4 Lasa Supergenerics Limited
9.4.1 Lasa Supergenerics Limited Basic Information
9.4.2 Lasa Supergenerics Limited Anti-helminthic Drugs Product Overview
9.4.3 Lasa Supergenerics Limited Anti-helminthic Drugs Product Market Performance
9.4.4 Lasa Supergenerics Limited Business Overview
9.4.5 Lasa Supergenerics Limited Recent Developments
9.5 Fredun Pharmaceuticals Ltd
9.5.1 Fredun Pharmaceuticals Ltd Basic Information
9.5.2 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Overview
9.5.3 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Market Performance
9.5.4 Fredun Pharmaceuticals Ltd Business Overview
9.5.5 Fredun Pharmaceuticals Ltd Recent Developments
9.6 Salius Pharma
9.6.1 Salius Pharma Basic Information
9.6.2 Salius Pharma Anti-helminthic Drugs Product Overview
9.6.3 Salius Pharma Anti-helminthic Drugs Product Market Performance
9.6.4 Salius Pharma Business Overview
9.6.5 Salius Pharma Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Basic Information
9.7.2 Johnson and Johnson Anti-helminthic Drugs Product Overview
9.7.3 Johnson and Johnson Anti-helminthic Drugs Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Amneal Pharmaceuticals
9.8.1 Amneal Pharmaceuticals Basic Information
9.8.2 Amneal Pharmaceuticals Anti-helminthic Drugs Product Overview
9.8.3 Amneal Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.8.4 Amneal Pharmaceuticals Business Overview
9.8.5 Amneal Pharmaceuticals Recent Developments
9.9 Cadila Pharmaceuticals
9.9.1 Cadila Pharmaceuticals Basic Information
9.9.2 Cadila Pharmaceuticals Anti-helminthic Drugs Product Overview
9.9.3 Cadila Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.9.4 Cadila Pharmaceuticals Business Overview
9.9.5 Cadila Pharmaceuticals Recent Developments
9.10 Eipico
9.10.1 Eipico Basic Information
9.10.2 Eipico Anti-helminthic Drugs Product Overview
9.10.3 Eipico Anti-helminthic Drugs Product Market Performance
9.10.4 Eipico Business Overview
9.10.5 Eipico Recent Developments
9.11 Esteve Pharmaceuticals
9.11.1 Esteve Pharmaceuticals Basic Information
9.11.2 Esteve Pharmaceuticals Anti-helminthic Drugs Product Overview
9.11.3 Esteve Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.11.4 Esteve Pharmaceuticals Business Overview
9.11.5 Esteve Pharmaceuticals Recent Developments
9.12 Merck
9.12.1 Merck Basic Information
9.12.2 Merck Anti-helminthic Drugs Product Overview
9.12.3 Merck Anti-helminthic Drugs Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 Shanghai Tengrui Pharmaceutical Co.
9.13.1 Shanghai Tengrui Pharmaceutical Co. Basic Information
9.13.2 Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.13.3 Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.13.4 Shanghai Tengrui Pharmaceutical Co. Business Overview
9.13.5 Shanghai Tengrui Pharmaceutical Co. Recent Developments
9.14 Ltd.
9.14.1 Ltd. Basic Information
9.14.2 Ltd. Anti-helminthic Drugs Product Overview
9.14.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.14.4 Ltd. Business Overview
9.14.5 Ltd. Recent Developments
9.15 Shaanxi Hanwang Pharmaceutical Co.
9.15.1 Shaanxi Hanwang Pharmaceutical Co. Basic Information
9.15.2 Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.15.3 Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.15.4 Shaanxi Hanwang Pharmaceutical Co. Business Overview
9.15.5 Shaanxi Hanwang Pharmaceutical Co. Recent Developments
9.16 Ltd.
9.16.1 Ltd. Basic Information
9.16.2 Ltd. Anti-helminthic Drugs Product Overview
9.16.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.16.4 Ltd. Business Overview
9.16.5 Ltd. Recent Developments
9.17 Beijing Taiyang Pharmaceutical Co.
9.17.1 Beijing Taiyang Pharmaceutical Co. Basic Information
9.17.2 Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.17.3 Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.17.4 Beijing Taiyang Pharmaceutical Co. Business Overview
9.17.5 Beijing Taiyang Pharmaceutical Co. Recent Developments
9.18 Ltd.
9.18.1 Ltd. Basic Information
9.18.2 Ltd. Anti-helminthic Drugs Product Overview
9.18.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.18.4 Ltd. Business Overview
9.18.5 Ltd. Recent Developments
9.19 Guilin Nanyao Pharmaceutical Co.
9.19.1 Guilin Nanyao Pharmaceutical Co. Basic Information
9.19.2 Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.19.3 Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.19.4 Guilin Nanyao Pharmaceutical Co. Business Overview
9.19.5 Guilin Nanyao Pharmaceutical Co. Recent Developments
9.20 Ltd.
9.20.1 Ltd. Basic Information
9.20.2 Ltd. Anti-helminthic Drugs Product Overview
9.20.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.20.4 Ltd. Business Overview
9.20.5 Ltd. Recent Developments
9.21 Fujian Dongrui Pharmaceutical Co.
9.21.1 Fujian Dongrui Pharmaceutical Co. Basic Information
9.21.2 Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.21.3 Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.21.4 Fujian Dongrui Pharmaceutical Co. Business Overview
9.21.5 Fujian Dongrui Pharmaceutical Co. Recent Developments
9.22 Ltd.
9.22.1 Ltd. Basic Information
9.22.2 Ltd. Anti-helminthic Drugs Product Overview
9.22.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.22.4 Ltd. Business Overview
9.22.5 Ltd. Recent Developments
9.23 Jiaozuo Furuitang Pharmaceutical Co.
9.23.1 Jiaozuo Furuitang Pharmaceutical Co. Basic Information
9.23.2 Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.23.3 Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.23.4 Jiaozuo Furuitang Pharmaceutical Co. Business Overview
9.23.5 Jiaozuo Furuitang Pharmaceutical Co. Recent Developments
9.24 Ltd.
9.24.1 Ltd. Basic Information
9.24.2 Ltd. Anti-helminthic Drugs Product Overview
9.24.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.24.4 Ltd. Business Overview
9.24.5 Ltd. Recent Developments
9.25 Shaoxing Minsheng Pharmaceutical Co.
9.25.1 Shaoxing Minsheng Pharmaceutical Co. Basic Information
9.25.2 Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.25.3 Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.25.4 Shaoxing Minsheng Pharmaceutical Co. Business Overview
9.25.5 Shaoxing Minsheng Pharmaceutical Co. Recent Developments
9.26 Ltd.
9.26.1 Ltd. Basic Information
9.26.2 Ltd. Anti-helminthic Drugs Product Overview
9.26.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.26.4 Ltd. Business Overview
9.26.5 Ltd. Recent Developments
9.27 Chengdu Hengda Pharmaceutical Co.
9.27.1 Chengdu Hengda Pharmaceutical Co. Basic Information
9.27.2 Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.27.3 Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.27.4 Chengdu Hengda Pharmaceutical Co. Business Overview
9.27.5 Chengdu Hengda Pharmaceutical Co. Recent Developments
9.28 Ltd.
9.28.1 Ltd. Basic Information
9.28.2 Ltd. Anti-helminthic Drugs Product Overview
9.28.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.28.4 Ltd. Business Overview
9.28.5 Ltd. Recent Developments
9.29 China Resources Sanjiu (Beijing) Pharmaceutical Co.
9.29.1 China Resources Sanjiu (Beijing) Pharmaceutical Co. Basic Information
9.29.2 China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.29.3 China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.29.4 China Resources Sanjiu (Beijing) Pharmaceutical Co. Business Overview
9.29.5 China Resources Sanjiu (Beijing) Pharmaceutical Co. Recent Developments
9.30 Ltd.
9.30.1 Ltd. Basic Information
9.30.2 Ltd. Anti-helminthic Drugs Product Overview
9.30.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.30.4 Ltd. Business Overview
9.30.5 Ltd. Recent Developments
10 ANTI-HELMINTHIC DRUGS MARKET FORECAST BY REGION
10.1 Global Anti-helminthic Drugs Market Size Forecast
10.2 Global Anti-helminthic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-helminthic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Anti-helminthic Drugs Market Size Forecast by Region
10.2.4 South America Anti-helminthic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Anti-helminthic Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Anti-helminthic Drugs Market Forecast by Type (2026-2033)
11.2 Global Anti-helminthic Drugs Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Anti-helminthic Drugs
1.2 Key Market Segments
1.2.1 Anti-helminthic Drugs Segment by Type
1.2.2 Anti-helminthic Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ANTI-HELMINTHIC DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ANTI-HELMINTHIC DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Anti-helminthic Drugs Product Life Cycle
3.3 Global Anti-helminthic Drugs Revenue Market Share by Company (2020-2025)
3.4 Anti-helminthic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.5 Anti-helminthic Drugs Company Headquarters, Area Served, Product Type
3.6 Anti-helminthic Drugs Market Competitive Situation and Trends
3.6.1 Anti-helminthic Drugs Market Concentration Rate
3.6.2 Global 5 and 10 Largest Anti-helminthic Drugs Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 ANTI-HELMINTHIC DRUGS VALUE CHAIN ANALYSIS
4.1 Anti-helminthic Drugs Value Chain Analysis
4.2 Midstream Market Analysis
4.3 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ANTI-HELMINTHIC DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Anti-helminthic Drugs Market Porter's Five Forces Analysis
6 ANTI-HELMINTHIC DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Anti-helminthic Drugs Market Size Market Share by Type (2020-2025)
6.3 Global Anti-helminthic Drugs Market Size Growth Rate by Type (2021-2025)
7 ANTI-HELMINTHIC DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Anti-helminthic Drugs Market Size (M USD) by Application (2020-2025)
7.3 Global Anti-helminthic Drugs Sales Growth Rate by Application (2020-2025)
8 ANTI-HELMINTHIC DRUGS MARKET SEGMENTATION BY REGION
8.1 Global Anti-helminthic Drugs Market Size by Region
8.1.1 Global Anti-helminthic Drugs Market Size by Region
8.1.2 Global Anti-helminthic Drugs Market Size Market Share by Region
8.2 North America
8.2.1 North America Anti-helminthic Drugs Market Size by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Anti-helminthic Drugs Market Size by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Spain
8.4 Asia Pacific
8.4.1 Asia Pacific Anti-helminthic Drugs Market Size by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Anti-helminthic Drugs Market Size by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Anti-helminthic Drugs Market Size by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 GlaxoSmithKline
9.1.1 GlaxoSmithKline Basic Information
9.1.2 GlaxoSmithKline Anti-helminthic Drugs Product Overview
9.1.3 GlaxoSmithKline Anti-helminthic Drugs Product Market Performance
9.1.4 GlaxoSmithKline SWOT Analysis
9.1.5 GlaxoSmithKline Business Overview
9.1.6 GlaxoSmithKline Recent Developments
9.2 Sequent Scientific
9.2.1 Sequent Scientific Basic Information
9.2.2 Sequent Scientific Anti-helminthic Drugs Product Overview
9.2.3 Sequent Scientific Anti-helminthic Drugs Product Market Performance
9.2.4 Sequent Scientific SWOT Analysis
9.2.5 Sequent Scientific Business Overview
9.2.6 Sequent Scientific Recent Developments
9.3 K.A. Malle Pharmaceuticals
9.3.1 K.A. Malle Pharmaceuticals Basic Information
9.3.2 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Overview
9.3.3 K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.3.4 K.A. Malle Pharmaceuticals SWOT Analysis
9.3.5 K.A. Malle Pharmaceuticals Business Overview
9.3.6 K.A. Malle Pharmaceuticals Recent Developments
9.4 Lasa Supergenerics Limited
9.4.1 Lasa Supergenerics Limited Basic Information
9.4.2 Lasa Supergenerics Limited Anti-helminthic Drugs Product Overview
9.4.3 Lasa Supergenerics Limited Anti-helminthic Drugs Product Market Performance
9.4.4 Lasa Supergenerics Limited Business Overview
9.4.5 Lasa Supergenerics Limited Recent Developments
9.5 Fredun Pharmaceuticals Ltd
9.5.1 Fredun Pharmaceuticals Ltd Basic Information
9.5.2 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Overview
9.5.3 Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Market Performance
9.5.4 Fredun Pharmaceuticals Ltd Business Overview
9.5.5 Fredun Pharmaceuticals Ltd Recent Developments
9.6 Salius Pharma
9.6.1 Salius Pharma Basic Information
9.6.2 Salius Pharma Anti-helminthic Drugs Product Overview
9.6.3 Salius Pharma Anti-helminthic Drugs Product Market Performance
9.6.4 Salius Pharma Business Overview
9.6.5 Salius Pharma Recent Developments
9.7 Johnson and Johnson
9.7.1 Johnson and Johnson Basic Information
9.7.2 Johnson and Johnson Anti-helminthic Drugs Product Overview
9.7.3 Johnson and Johnson Anti-helminthic Drugs Product Market Performance
9.7.4 Johnson and Johnson Business Overview
9.7.5 Johnson and Johnson Recent Developments
9.8 Amneal Pharmaceuticals
9.8.1 Amneal Pharmaceuticals Basic Information
9.8.2 Amneal Pharmaceuticals Anti-helminthic Drugs Product Overview
9.8.3 Amneal Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.8.4 Amneal Pharmaceuticals Business Overview
9.8.5 Amneal Pharmaceuticals Recent Developments
9.9 Cadila Pharmaceuticals
9.9.1 Cadila Pharmaceuticals Basic Information
9.9.2 Cadila Pharmaceuticals Anti-helminthic Drugs Product Overview
9.9.3 Cadila Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.9.4 Cadila Pharmaceuticals Business Overview
9.9.5 Cadila Pharmaceuticals Recent Developments
9.10 Eipico
9.10.1 Eipico Basic Information
9.10.2 Eipico Anti-helminthic Drugs Product Overview
9.10.3 Eipico Anti-helminthic Drugs Product Market Performance
9.10.4 Eipico Business Overview
9.10.5 Eipico Recent Developments
9.11 Esteve Pharmaceuticals
9.11.1 Esteve Pharmaceuticals Basic Information
9.11.2 Esteve Pharmaceuticals Anti-helminthic Drugs Product Overview
9.11.3 Esteve Pharmaceuticals Anti-helminthic Drugs Product Market Performance
9.11.4 Esteve Pharmaceuticals Business Overview
9.11.5 Esteve Pharmaceuticals Recent Developments
9.12 Merck
9.12.1 Merck Basic Information
9.12.2 Merck Anti-helminthic Drugs Product Overview
9.12.3 Merck Anti-helminthic Drugs Product Market Performance
9.12.4 Merck Business Overview
9.12.5 Merck Recent Developments
9.13 Shanghai Tengrui Pharmaceutical Co.
9.13.1 Shanghai Tengrui Pharmaceutical Co. Basic Information
9.13.2 Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.13.3 Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.13.4 Shanghai Tengrui Pharmaceutical Co. Business Overview
9.13.5 Shanghai Tengrui Pharmaceutical Co. Recent Developments
9.14 Ltd.
9.14.1 Ltd. Basic Information
9.14.2 Ltd. Anti-helminthic Drugs Product Overview
9.14.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.14.4 Ltd. Business Overview
9.14.5 Ltd. Recent Developments
9.15 Shaanxi Hanwang Pharmaceutical Co.
9.15.1 Shaanxi Hanwang Pharmaceutical Co. Basic Information
9.15.2 Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.15.3 Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.15.4 Shaanxi Hanwang Pharmaceutical Co. Business Overview
9.15.5 Shaanxi Hanwang Pharmaceutical Co. Recent Developments
9.16 Ltd.
9.16.1 Ltd. Basic Information
9.16.2 Ltd. Anti-helminthic Drugs Product Overview
9.16.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.16.4 Ltd. Business Overview
9.16.5 Ltd. Recent Developments
9.17 Beijing Taiyang Pharmaceutical Co.
9.17.1 Beijing Taiyang Pharmaceutical Co. Basic Information
9.17.2 Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.17.3 Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.17.4 Beijing Taiyang Pharmaceutical Co. Business Overview
9.17.5 Beijing Taiyang Pharmaceutical Co. Recent Developments
9.18 Ltd.
9.18.1 Ltd. Basic Information
9.18.2 Ltd. Anti-helminthic Drugs Product Overview
9.18.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.18.4 Ltd. Business Overview
9.18.5 Ltd. Recent Developments
9.19 Guilin Nanyao Pharmaceutical Co.
9.19.1 Guilin Nanyao Pharmaceutical Co. Basic Information
9.19.2 Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.19.3 Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.19.4 Guilin Nanyao Pharmaceutical Co. Business Overview
9.19.5 Guilin Nanyao Pharmaceutical Co. Recent Developments
9.20 Ltd.
9.20.1 Ltd. Basic Information
9.20.2 Ltd. Anti-helminthic Drugs Product Overview
9.20.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.20.4 Ltd. Business Overview
9.20.5 Ltd. Recent Developments
9.21 Fujian Dongrui Pharmaceutical Co.
9.21.1 Fujian Dongrui Pharmaceutical Co. Basic Information
9.21.2 Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.21.3 Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.21.4 Fujian Dongrui Pharmaceutical Co. Business Overview
9.21.5 Fujian Dongrui Pharmaceutical Co. Recent Developments
9.22 Ltd.
9.22.1 Ltd. Basic Information
9.22.2 Ltd. Anti-helminthic Drugs Product Overview
9.22.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.22.4 Ltd. Business Overview
9.22.5 Ltd. Recent Developments
9.23 Jiaozuo Furuitang Pharmaceutical Co.
9.23.1 Jiaozuo Furuitang Pharmaceutical Co. Basic Information
9.23.2 Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.23.3 Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.23.4 Jiaozuo Furuitang Pharmaceutical Co. Business Overview
9.23.5 Jiaozuo Furuitang Pharmaceutical Co. Recent Developments
9.24 Ltd.
9.24.1 Ltd. Basic Information
9.24.2 Ltd. Anti-helminthic Drugs Product Overview
9.24.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.24.4 Ltd. Business Overview
9.24.5 Ltd. Recent Developments
9.25 Shaoxing Minsheng Pharmaceutical Co.
9.25.1 Shaoxing Minsheng Pharmaceutical Co. Basic Information
9.25.2 Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.25.3 Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.25.4 Shaoxing Minsheng Pharmaceutical Co. Business Overview
9.25.5 Shaoxing Minsheng Pharmaceutical Co. Recent Developments
9.26 Ltd.
9.26.1 Ltd. Basic Information
9.26.2 Ltd. Anti-helminthic Drugs Product Overview
9.26.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.26.4 Ltd. Business Overview
9.26.5 Ltd. Recent Developments
9.27 Chengdu Hengda Pharmaceutical Co.
9.27.1 Chengdu Hengda Pharmaceutical Co. Basic Information
9.27.2 Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.27.3 Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.27.4 Chengdu Hengda Pharmaceutical Co. Business Overview
9.27.5 Chengdu Hengda Pharmaceutical Co. Recent Developments
9.28 Ltd.
9.28.1 Ltd. Basic Information
9.28.2 Ltd. Anti-helminthic Drugs Product Overview
9.28.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.28.4 Ltd. Business Overview
9.28.5 Ltd. Recent Developments
9.29 China Resources Sanjiu (Beijing) Pharmaceutical Co.
9.29.1 China Resources Sanjiu (Beijing) Pharmaceutical Co. Basic Information
9.29.2 China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Product Overview
9.29.3 China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Product Market Performance
9.29.4 China Resources Sanjiu (Beijing) Pharmaceutical Co. Business Overview
9.29.5 China Resources Sanjiu (Beijing) Pharmaceutical Co. Recent Developments
9.30 Ltd.
9.30.1 Ltd. Basic Information
9.30.2 Ltd. Anti-helminthic Drugs Product Overview
9.30.3 Ltd. Anti-helminthic Drugs Product Market Performance
9.30.4 Ltd. Business Overview
9.30.5 Ltd. Recent Developments
10 ANTI-HELMINTHIC DRUGS MARKET FORECAST BY REGION
10.1 Global Anti-helminthic Drugs Market Size Forecast
10.2 Global Anti-helminthic Drugs Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Anti-helminthic Drugs Market Size Forecast by Country
10.2.3 Asia Pacific Anti-helminthic Drugs Market Size Forecast by Region
10.2.4 South America Anti-helminthic Drugs Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Sales of Anti-helminthic Drugs by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
11.1 Global Anti-helminthic Drugs Market Forecast by Type (2026-2033)
11.2 Global Anti-helminthic Drugs Market Forecast by Application (2026-2033)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-helminthic Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-helminthic Drugs Revenue (M USD) by Company (2020-2025)
Table 6. Global Anti-helminthic Drugs Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-helminthic Drugs as of 2024)
Table 8. Anti-helminthic Drugs Company Headquarters and Area Served
Table 9. Company Anti-helminthic Drugs Product Type
Table 10. Global Anti-helminthic Drugs Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Anti-helminthic Drugs Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Anti-helminthic Drugs Market Size by Type (M USD)
Table 21. Global Anti-helminthic Drugs Market Size (M USD) by Type (2020-2025)
Table 22. Global Anti-helminthic Drugs Market Size Share by Type (2020-2025)
Table 23. Global Anti-helminthic Drugs Market Size Growth Rate by Type (2021-2025)
Table 24. Global Anti-helminthic Drugs Market Size by Application
Table 25. Global Anti-helminthic Drugs Market Size by Application (2020-2025) & (M USD)
Table 26. Global Anti-helminthic Drugs Market Share by Application (2020-2025)
Table 27. Global Anti-helminthic Drugs Sales Growth Rate by Application (2020-2025)
Table 28. Global Anti-helminthic Drugs Market Size by Region (2020-2025) & (M USD)
Table 29. Global Anti-helminthic Drugs Market Size Market Share by Region (2020-2025)
Table 30. North America Anti-helminthic Drugs Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Anti-helminthic Drugs Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Anti-helminthic Drugs Market Size by Region (2020-2025) & (M USD)
Table 33. South America Anti-helminthic Drugs Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Anti-helminthic Drugs Market Size by Region (2020-2025) & (M USD)
Table 35. GlaxoSmithKline Basic Information
Table 36. GlaxoSmithKline Anti-helminthic Drugs Product Overview
Table 37. GlaxoSmithKline Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Business Overview
Table 40. GlaxoSmithKline Recent Developments
Table 41. Sequent Scientific Basic Information
Table 42. Sequent Scientific Anti-helminthic Drugs Product Overview
Table 43. Sequent Scientific Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Sequent Scientific SWOT Analysis
Table 45. Sequent Scientific Business Overview
Table 46. Sequent Scientific Recent Developments
Table 47. K.A. Malle Pharmaceuticals Basic Information
Table 48. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 49. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 50. K.A. Malle Pharmaceuticals SWOT Analysis
Table 51. K.A. Malle Pharmaceuticals Business Overview
Table 52. K.A. Malle Pharmaceuticals Recent Developments
Table 53. Lasa Supergenerics Limited Basic Information
Table 54. Lasa Supergenerics Limited Anti-helminthic Drugs Product Overview
Table 55. Lasa Supergenerics Limited Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Lasa Supergenerics Limited Business Overview
Table 57. Lasa Supergenerics Limited Recent Developments
Table 58. Fredun Pharmaceuticals Ltd Basic Information
Table 59. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Overview
Table 60. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Fredun Pharmaceuticals Ltd Business Overview
Table 62. Fredun Pharmaceuticals Ltd Recent Developments
Table 63. Salius Pharma Basic Information
Table 64. Salius Pharma Anti-helminthic Drugs Product Overview
Table 65. Salius Pharma Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Salius Pharma Business Overview
Table 67. Salius Pharma Recent Developments
Table 68. Johnson and Johnson Basic Information
Table 69. Johnson and Johnson Anti-helminthic Drugs Product Overview
Table 70. Johnson and Johnson Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson Recent Developments
Table 73. Amneal Pharmaceuticals Basic Information
Table 74. Amneal Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 75. Amneal Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Amneal Pharmaceuticals Business Overview
Table 77. Amneal Pharmaceuticals Recent Developments
Table 78. Cadila Pharmaceuticals Basic Information
Table 79. Cadila Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 80. Cadila Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Cadila Pharmaceuticals Business Overview
Table 82. Cadila Pharmaceuticals Recent Developments
Table 83. Eipico Basic Information
Table 84. Eipico Anti-helminthic Drugs Product Overview
Table 85. Eipico Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Eipico Business Overview
Table 87. Eipico Recent Developments
Table 88. Esteve Pharmaceuticals Basic Information
Table 89. Esteve Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 90. Esteve Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Esteve Pharmaceuticals Business Overview
Table 92. Esteve Pharmaceuticals Recent Developments
Table 93. Merck Basic Information
Table 94. Merck Anti-helminthic Drugs Product Overview
Table 95. Merck Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Merck Business Overview
Table 97. Merck Recent Developments
Table 98. Shanghai Tengrui Pharmaceutical Co. Basic Information
Table 99. Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 100. Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Shanghai Tengrui Pharmaceutical Co. Business Overview
Table 102. Shanghai Tengrui Pharmaceutical Co. Recent Developments
Table 103. Ltd. Basic Information
Table 104. Ltd. Anti-helminthic Drugs Product Overview
Table 105. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Ltd. Business Overview
Table 107. Ltd. Recent Developments
Table 108. Shaanxi Hanwang Pharmaceutical Co. Basic Information
Table 109. Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 110. Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Shaanxi Hanwang Pharmaceutical Co. Business Overview
Table 112. Shaanxi Hanwang Pharmaceutical Co. Recent Developments
Table 113. Ltd. Basic Information
Table 114. Ltd. Anti-helminthic Drugs Product Overview
Table 115. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Ltd. Business Overview
Table 117. Ltd. Recent Developments
Table 118. Beijing Taiyang Pharmaceutical Co. Basic Information
Table 119. Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 120. Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Beijing Taiyang Pharmaceutical Co. Business Overview
Table 122. Beijing Taiyang Pharmaceutical Co. Recent Developments
Table 123. Ltd. Basic Information
Table 124. Ltd. Anti-helminthic Drugs Product Overview
Table 125. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 126. Ltd. Business Overview
Table 127. Ltd. Recent Developments
Table 128. Guilin Nanyao Pharmaceutical Co. Basic Information
Table 129. Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 130. Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Guilin Nanyao Pharmaceutical Co. Business Overview
Table 132. Guilin Nanyao Pharmaceutical Co. Recent Developments
Table 133. Ltd. Basic Information
Table 134. Ltd. Anti-helminthic Drugs Product Overview
Table 135. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 136. Ltd. Business Overview
Table 137. Ltd. Recent Developments
Table 138. Fujian Dongrui Pharmaceutical Co. Basic Information
Table 139. Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 140. Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 141. Fujian Dongrui Pharmaceutical Co. Business Overview
Table 142. Fujian Dongrui Pharmaceutical Co. Recent Developments
Table 143. Ltd. Basic Information
Table 144. Ltd. Anti-helminthic Drugs Product Overview
Table 145. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 146. Ltd. Business Overview
Table 147. Ltd. Recent Developments
Table 148. Jiaozuo Furuitang Pharmaceutical Co. Basic Information
Table 149. Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 150. Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 151. Jiaozuo Furuitang Pharmaceutical Co. Business Overview
Table 152. Jiaozuo Furuitang Pharmaceutical Co. Recent Developments
Table 153. Ltd. Basic Information
Table 154. Ltd. Anti-helminthic Drugs Product Overview
Table 155. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 156. Ltd. Business Overview
Table 157. Ltd. Recent Developments
Table 158. Shaoxing Minsheng Pharmaceutical Co. Basic Information
Table 159. Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 160. Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 161. Shaoxing Minsheng Pharmaceutical Co. Business Overview
Table 162. Shaoxing Minsheng Pharmaceutical Co. Recent Developments
Table 163. Ltd. Basic Information
Table 164. Ltd. Anti-helminthic Drugs Product Overview
Table 165. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 166. Ltd. Business Overview
Table 167. Ltd. Recent Developments
Table 168. Chengdu Hengda Pharmaceutical Co. Basic Information
Table 169. Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 170. Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 171. Chengdu Hengda Pharmaceutical Co. Business Overview
Table 172. Chengdu Hengda Pharmaceutical Co. Recent Developments
Table 173. Ltd. Basic Information
Table 174. Ltd. Anti-helminthic Drugs Product Overview
Table 175. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 176. Ltd. Business Overview
Table 177. Ltd. Recent Developments
Table 178. China Resources Sanjiu (Beijing) Pharmaceutical Co. Basic Information
Table 179. China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 180. China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 181. China Resources Sanjiu (Beijing) Pharmaceutical Co. Business Overview
Table 182. China Resources Sanjiu (Beijing) Pharmaceutical Co. Recent Developments
Table 183. Ltd. Basic Information
Table 184. Ltd. Anti-helminthic Drugs Product Overview
Table 185. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 186. Ltd. Business Overview
Table 187. Ltd. Recent Developments
Table 188. Global Anti-helminthic Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 189. North America Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 190. Europe Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 191. Asia Pacific Anti-helminthic Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 192. South America Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 193. Middle East and Africa Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 194. Global Anti-helminthic Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 195. Global Anti-helminthic Drugs Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Anti-helminthic Drugs Market Size Comparison by Region (M USD)
Table 5. Global Anti-helminthic Drugs Revenue (M USD) by Company (2020-2025)
Table 6. Global Anti-helminthic Drugs Revenue Share by Company (2020-2025)
Table 7. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-helminthic Drugs as of 2024)
Table 8. Anti-helminthic Drugs Company Headquarters and Area Served
Table 9. Company Anti-helminthic Drugs Product Type
Table 10. Global Anti-helminthic Drugs Company Market Concentration Ratio (CR5 and HHI)
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. Midstream Market Analysis
Table 13. Downstream Customer Analysis
Table 14. Key Development Trends
Table 15. Driving Factors
Table 16. Anti-helminthic Drugs Market Challenges
Table 17. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 18. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 19. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 20. Global Anti-helminthic Drugs Market Size by Type (M USD)
Table 21. Global Anti-helminthic Drugs Market Size (M USD) by Type (2020-2025)
Table 22. Global Anti-helminthic Drugs Market Size Share by Type (2020-2025)
Table 23. Global Anti-helminthic Drugs Market Size Growth Rate by Type (2021-2025)
Table 24. Global Anti-helminthic Drugs Market Size by Application
Table 25. Global Anti-helminthic Drugs Market Size by Application (2020-2025) & (M USD)
Table 26. Global Anti-helminthic Drugs Market Share by Application (2020-2025)
Table 27. Global Anti-helminthic Drugs Sales Growth Rate by Application (2020-2025)
Table 28. Global Anti-helminthic Drugs Market Size by Region (2020-2025) & (M USD)
Table 29. Global Anti-helminthic Drugs Market Size Market Share by Region (2020-2025)
Table 30. North America Anti-helminthic Drugs Market Size by Country (2020-2025) & (M USD)
Table 31. Europe Anti-helminthic Drugs Market Size by Country (2020-2025) & (M USD)
Table 32. Asia Pacific Anti-helminthic Drugs Market Size by Region (2020-2025) & (M USD)
Table 33. South America Anti-helminthic Drugs Market Size by Country (2020-2025) & (M USD)
Table 34. Middle East and Africa Anti-helminthic Drugs Market Size by Region (2020-2025) & (M USD)
Table 35. GlaxoSmithKline Basic Information
Table 36. GlaxoSmithKline Anti-helminthic Drugs Product Overview
Table 37. GlaxoSmithKline Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline Business Overview
Table 40. GlaxoSmithKline Recent Developments
Table 41. Sequent Scientific Basic Information
Table 42. Sequent Scientific Anti-helminthic Drugs Product Overview
Table 43. Sequent Scientific Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 44. Sequent Scientific SWOT Analysis
Table 45. Sequent Scientific Business Overview
Table 46. Sequent Scientific Recent Developments
Table 47. K.A. Malle Pharmaceuticals Basic Information
Table 48. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 49. K.A. Malle Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 50. K.A. Malle Pharmaceuticals SWOT Analysis
Table 51. K.A. Malle Pharmaceuticals Business Overview
Table 52. K.A. Malle Pharmaceuticals Recent Developments
Table 53. Lasa Supergenerics Limited Basic Information
Table 54. Lasa Supergenerics Limited Anti-helminthic Drugs Product Overview
Table 55. Lasa Supergenerics Limited Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 56. Lasa Supergenerics Limited Business Overview
Table 57. Lasa Supergenerics Limited Recent Developments
Table 58. Fredun Pharmaceuticals Ltd Basic Information
Table 59. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Product Overview
Table 60. Fredun Pharmaceuticals Ltd Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 61. Fredun Pharmaceuticals Ltd Business Overview
Table 62. Fredun Pharmaceuticals Ltd Recent Developments
Table 63. Salius Pharma Basic Information
Table 64. Salius Pharma Anti-helminthic Drugs Product Overview
Table 65. Salius Pharma Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 66. Salius Pharma Business Overview
Table 67. Salius Pharma Recent Developments
Table 68. Johnson and Johnson Basic Information
Table 69. Johnson and Johnson Anti-helminthic Drugs Product Overview
Table 70. Johnson and Johnson Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson Recent Developments
Table 73. Amneal Pharmaceuticals Basic Information
Table 74. Amneal Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 75. Amneal Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 76. Amneal Pharmaceuticals Business Overview
Table 77. Amneal Pharmaceuticals Recent Developments
Table 78. Cadila Pharmaceuticals Basic Information
Table 79. Cadila Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 80. Cadila Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 81. Cadila Pharmaceuticals Business Overview
Table 82. Cadila Pharmaceuticals Recent Developments
Table 83. Eipico Basic Information
Table 84. Eipico Anti-helminthic Drugs Product Overview
Table 85. Eipico Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 86. Eipico Business Overview
Table 87. Eipico Recent Developments
Table 88. Esteve Pharmaceuticals Basic Information
Table 89. Esteve Pharmaceuticals Anti-helminthic Drugs Product Overview
Table 90. Esteve Pharmaceuticals Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 91. Esteve Pharmaceuticals Business Overview
Table 92. Esteve Pharmaceuticals Recent Developments
Table 93. Merck Basic Information
Table 94. Merck Anti-helminthic Drugs Product Overview
Table 95. Merck Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 96. Merck Business Overview
Table 97. Merck Recent Developments
Table 98. Shanghai Tengrui Pharmaceutical Co. Basic Information
Table 99. Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 100. Shanghai Tengrui Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 101. Shanghai Tengrui Pharmaceutical Co. Business Overview
Table 102. Shanghai Tengrui Pharmaceutical Co. Recent Developments
Table 103. Ltd. Basic Information
Table 104. Ltd. Anti-helminthic Drugs Product Overview
Table 105. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 106. Ltd. Business Overview
Table 107. Ltd. Recent Developments
Table 108. Shaanxi Hanwang Pharmaceutical Co. Basic Information
Table 109. Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 110. Shaanxi Hanwang Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 111. Shaanxi Hanwang Pharmaceutical Co. Business Overview
Table 112. Shaanxi Hanwang Pharmaceutical Co. Recent Developments
Table 113. Ltd. Basic Information
Table 114. Ltd. Anti-helminthic Drugs Product Overview
Table 115. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 116. Ltd. Business Overview
Table 117. Ltd. Recent Developments
Table 118. Beijing Taiyang Pharmaceutical Co. Basic Information
Table 119. Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 120. Beijing Taiyang Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 121. Beijing Taiyang Pharmaceutical Co. Business Overview
Table 122. Beijing Taiyang Pharmaceutical Co. Recent Developments
Table 123. Ltd. Basic Information
Table 124. Ltd. Anti-helminthic Drugs Product Overview
Table 125. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 126. Ltd. Business Overview
Table 127. Ltd. Recent Developments
Table 128. Guilin Nanyao Pharmaceutical Co. Basic Information
Table 129. Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 130. Guilin Nanyao Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 131. Guilin Nanyao Pharmaceutical Co. Business Overview
Table 132. Guilin Nanyao Pharmaceutical Co. Recent Developments
Table 133. Ltd. Basic Information
Table 134. Ltd. Anti-helminthic Drugs Product Overview
Table 135. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 136. Ltd. Business Overview
Table 137. Ltd. Recent Developments
Table 138. Fujian Dongrui Pharmaceutical Co. Basic Information
Table 139. Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 140. Fujian Dongrui Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 141. Fujian Dongrui Pharmaceutical Co. Business Overview
Table 142. Fujian Dongrui Pharmaceutical Co. Recent Developments
Table 143. Ltd. Basic Information
Table 144. Ltd. Anti-helminthic Drugs Product Overview
Table 145. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 146. Ltd. Business Overview
Table 147. Ltd. Recent Developments
Table 148. Jiaozuo Furuitang Pharmaceutical Co. Basic Information
Table 149. Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 150. Jiaozuo Furuitang Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 151. Jiaozuo Furuitang Pharmaceutical Co. Business Overview
Table 152. Jiaozuo Furuitang Pharmaceutical Co. Recent Developments
Table 153. Ltd. Basic Information
Table 154. Ltd. Anti-helminthic Drugs Product Overview
Table 155. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 156. Ltd. Business Overview
Table 157. Ltd. Recent Developments
Table 158. Shaoxing Minsheng Pharmaceutical Co. Basic Information
Table 159. Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 160. Shaoxing Minsheng Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 161. Shaoxing Minsheng Pharmaceutical Co. Business Overview
Table 162. Shaoxing Minsheng Pharmaceutical Co. Recent Developments
Table 163. Ltd. Basic Information
Table 164. Ltd. Anti-helminthic Drugs Product Overview
Table 165. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 166. Ltd. Business Overview
Table 167. Ltd. Recent Developments
Table 168. Chengdu Hengda Pharmaceutical Co. Basic Information
Table 169. Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 170. Chengdu Hengda Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 171. Chengdu Hengda Pharmaceutical Co. Business Overview
Table 172. Chengdu Hengda Pharmaceutical Co. Recent Developments
Table 173. Ltd. Basic Information
Table 174. Ltd. Anti-helminthic Drugs Product Overview
Table 175. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 176. Ltd. Business Overview
Table 177. Ltd. Recent Developments
Table 178. China Resources Sanjiu (Beijing) Pharmaceutical Co. Basic Information
Table 179. China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Product Overview
Table 180. China Resources Sanjiu (Beijing) Pharmaceutical Co. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 181. China Resources Sanjiu (Beijing) Pharmaceutical Co. Business Overview
Table 182. China Resources Sanjiu (Beijing) Pharmaceutical Co. Recent Developments
Table 183. Ltd. Basic Information
Table 184. Ltd. Anti-helminthic Drugs Product Overview
Table 185. Ltd. Anti-helminthic Drugs Revenue (M USD) and Gross Margin (2020-2025)
Table 186. Ltd. Business Overview
Table 187. Ltd. Recent Developments
Table 188. Global Anti-helminthic Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 189. North America Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 190. Europe Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 191. Asia Pacific Anti-helminthic Drugs Market Size Forecast by Region (2026-2033) & (M USD)
Table 192. South America Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 193. Middle East and Africa Anti-helminthic Drugs Market Size Forecast by Country (2026-2033) & (M USD)
Table 194. Global Anti-helminthic Drugs Market Size Forecast by Type (2026-2033) & (M USD)
Table 195. Global Anti-helminthic Drugs Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Industry Chain of Anti-helminthic Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-helminthic Drugs Market Size (M USD), 2024-2033
Figure 5. Global Anti-helminthic Drugs Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Anti-helminthic Drugs Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Anti-helminthic Drugs Product Life Cycle
Figure 12. Global Anti-helminthic Drugs Revenue Share by Company in 2024
Figure 13. Anti-helminthic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Anti-helminthic Drugs Revenue in 2024
Figure 15. Value Chain Map of Anti-helminthic Drugs
Figure 16. Global Anti-helminthic Drugs Market PEST Analysis
Figure 17. Global Anti-helminthic Drugs Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Anti-helminthic Drugs Market Share by Type
Figure 20. Market Size Share of Anti-helminthic Drugs by Type (2020-2025)
Figure 21. Market Size Share of Anti-helminthic Drugs by Type in 2024
Figure 22. Global Anti-helminthic Drugs Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Anti-helminthic Drugs Market Share by Application
Figure 25. Global Anti-helminthic Drugs Market Share by Application (2020-2025)
Figure 26. Global Anti-helminthic Drugs Market Share by Application in 2024
Figure 27. Global Anti-helminthic Drugs Sales Growth Rate by Application (2020-2025)
Figure 28. Global Anti-helminthic Drugs Market Size Market Share by Region (2020-2025)
Figure 29. North America Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Anti-helminthic Drugs Market Size Market Share by Country in 2024
Figure 31. U.S. Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Anti-helminthic Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Anti-helminthic Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Anti-helminthic Drugs Market Share by Country in 2024
Figure 36. Germany Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Anti-helminthic Drugs Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Anti-helminthic Drugs Market Size Market Share by Region in 2024
Figure 43. China Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Anti-helminthic Drugs Market Size and Growth Rate (M USD)
Figure 49. South America Anti-helminthic Drugs Market Size Market Share by Country in 2024
Figure 50. Brazil Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Anti-helminthic Drugs Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Anti-helminthic Drugs Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Anti-helminthic Drugs Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Anti-helminthic Drugs Market Share Forecast by Type (2026-2033)
Figure 62. Global Anti-helminthic Drugs Market Share Forecast by Application (2026-2033)
Figure 1. Industry Chain of Anti-helminthic Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Anti-helminthic Drugs Market Size (M USD), 2024-2033
Figure 5. Global Anti-helminthic Drugs Market Size (M USD) (2020-2033)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 8. Evaluation Matrix of Regional Market Development Potential
Figure 9. Anti-helminthic Drugs Market Size by Country (M USD)
Figure 10. Company Assessment Quadrant
Figure 11. Global Anti-helminthic Drugs Product Life Cycle
Figure 12. Global Anti-helminthic Drugs Revenue Share by Company in 2024
Figure 13. Anti-helminthic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 14. The Global 5 and 10 Largest Players: Market Share by Anti-helminthic Drugs Revenue in 2024
Figure 15. Value Chain Map of Anti-helminthic Drugs
Figure 16. Global Anti-helminthic Drugs Market PEST Analysis
Figure 17. Global Anti-helminthic Drugs Market Porter's Five Forces Analysis
Figure 18. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 19. Global Anti-helminthic Drugs Market Share by Type
Figure 20. Market Size Share of Anti-helminthic Drugs by Type (2020-2025)
Figure 21. Market Size Share of Anti-helminthic Drugs by Type in 2024
Figure 22. Global Anti-helminthic Drugs Market Size Growth Rate by Type (2021-2025)
Figure 23. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 24. Global Anti-helminthic Drugs Market Share by Application
Figure 25. Global Anti-helminthic Drugs Market Share by Application (2020-2025)
Figure 26. Global Anti-helminthic Drugs Market Share by Application in 2024
Figure 27. Global Anti-helminthic Drugs Sales Growth Rate by Application (2020-2025)
Figure 28. Global Anti-helminthic Drugs Market Size Market Share by Region (2020-2025)
Figure 29. North America Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 30. North America Anti-helminthic Drugs Market Size Market Share by Country in 2024
Figure 31. U.S. Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 32. Canada Anti-helminthic Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 33. Mexico Anti-helminthic Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 34. Europe Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 35. Europe Anti-helminthic Drugs Market Share by Country in 2024
Figure 36. Germany Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 37. France Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 38. U.K. Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 39. Italy Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 40. Spain Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 41. Asia Pacific Anti-helminthic Drugs Market Size and Growth Rate (M USD)
Figure 42. Asia Pacific Anti-helminthic Drugs Market Size Market Share by Region in 2024
Figure 43. China Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. Japan Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 45. South Korea Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. India Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Southeast Asia Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 48. South America Anti-helminthic Drugs Market Size and Growth Rate (M USD)
Figure 49. South America Anti-helminthic Drugs Market Size Market Share by Country in 2024
Figure 50. Brazil Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Argentina Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 52. Columbia Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Middle East and Africa Anti-helminthic Drugs Market Size and Growth Rate (M USD)
Figure 54. Middle East and Africa Anti-helminthic Drugs Market Size Market Share by Region in 2024
Figure 55. Saudi Arabia Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. UAE Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. Egypt Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. Nigeria Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. South Africa Anti-helminthic Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Global Anti-helminthic Drugs Market Size Forecast (2020-2033) & (M USD)
Figure 61. Global Anti-helminthic Drugs Market Share Forecast by Type (2026-2033)
Figure 62. Global Anti-helminthic Drugs Market Share Forecast by Application (2026-2033)
